secwatch.observer — SEC 8-K summary
======================================

Issuer:     Q/C TECHNOLOGIES, INC. (QCLS)
CIK:        0001321834
Form:       8-K
Filed at:   2025-09-02T23:59:59+00:00
Accession:  0001641172-25-026167
Event type: m_and_a
Sentiment:  negative
Materiality: 0.80
Item codes: 1.01, 1.02, 3.02, 3.03, 5.03, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TNF Pharma raises $7M, acquires LPU Holdings for crypto mining, ends sarcopenia trial
--------------------------------------------------------------------------------

- $7M private placement: Series H convertible preferred (7% dividend, $5 conversion) and warrants for 1.4M shares at $5; expected close Sept 4, 2025.
- Agrees to acquire LPU Holdings for Series I convertible preferred convertible into 747,362 shares at $0.001/sh; contingent milestones; license with LightSolver for crypto mining laser hardware.
- Terminates Master Service Agreement with Prevail for Phase 2 sarcopenia/frailty trial; effective 30 days after Sept 2, 2025 notice.
- Director changes: Uzonwanne resigns; Glass steps down as President (stays CMO/Board); Bernstein appointed to Board; Silverman named Executive Chairman.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1321834/000164117225026167/0001641172-25-026167-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1321834/000164117225026167/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-026167

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer